Long-Term Renal Outcomes after Cisplatin Treatment (2016)

Peer-Reviewed Study · Tier 1 — Primary Document · Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD · July 7, 2016

Latcha S et al., 2016-07-07: Retrospective study of 821 adults treated with cisplatin at Memorial Sloan Kettering who survived at least five years. Acute kidney injury occurred in 31.5%, with lasting falls in eGFR.

AKI occurred in 31.5% of patients, with a median initial decline in eGFR of 10 ml/min per 1.73 m(2)

Abstract (Results)

Latcha S et al., 2016-07-07: Retrospective study of 821 adults treated with cisplatin at Memorial Sloan Kettering who survived at least five years. Acute kidney injury occurred in 31.5%, with lasting falls in eGFR. Comparator: none (single-cohort incidence, AKI defined as creatinine rise >25% within 30 days of cycle 1). Funder/COI not in the abstract. This is the closest primary source for 'up to 30%' – the measured figure is 31.5%, and the cohort is survivors of at least five years, so it is not a general incidence. Cumulative dose, age and baseline eGFR were analysed as predictors. Study type: uncontrolled series.